Found 43 matching trials
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects PHASE3 This study is a randomized controlled, open-label, multicenter phase III cl...
Show More Learn More & Join Trial
Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer PHASE3 This is a phase 3, multicenter, open-label, randomized active-controlled, p...
Show More Location
California Cancer Associates for Research and Excellence
Learn More & Join Trial
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma PHASE1 This is a feasibility study in patients with localized or metastatic soft t...
Show More Location
Monter Cancer Center (Northwell Health)
Learn More & Join Trial
A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma PHASE2 The eribulin, a microtubule-dynamics inhibitor was approved for specific su...
Show More Location
Severance Hospital, Yonsei University Health System
Learn More & Join Trial
SMMART Adaptive Clinical Treatment (ACT) Trial EARLY_PHASE1 SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh System PHASE1 This is an open-label, three-parallel group pharmacokinetic study. Patients...
Show More Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Learn More & Join Trial
A Study of Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01). N/A A Single-Center Retrospective Study About Efficacy and Safety of Eribulin-B...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
Halaven Post-Marketing Surveillance (PMS) N/A This is a PMS to observe the safety profile of Halaven in normal clinical p...
Show More Location
Multiple Locations
Learn More & Join Trial
A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma. PHASE2 This study intends to enroll patients with advanced soft tissue sarcoma, em...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer PHASE3 The primary objective of this study is to assess and compare the efficacy a...
Show More Location
HonorHealth Research Institute
Learn More & Join Trial